| Literature DB >> 17349040 |
Mariano J Alvarez1, Guillermo J Vila-Ortiz, Mariano C Salibe, Osvaldo L Podhajcer, Fernando J Pitossi.
Abstract
BACKGROUND: Reverse transcription followed by real-time PCR is widely used for quantification of specific mRNA, and with the use of double-stranded DNA binding dyes it is becoming a standard for microarray data validation. Despite the kinetic information generated by real-time PCR, most popular analysis methods assume constant amplification efficiency among samples, introducing strong biases when amplification efficiencies are not the same.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17349040 PMCID: PMC1838433 DOI: 10.1186/1471-2105-8-85
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Figure 1Models for PCR amplification efficiency. The effective amplification efficiency for each PCR cycle was calculated as T/T– 1, where Tand Twere the PCR product yield at cycles n and n+1 respectively. Data points are the effective amplification efficiency vs. PCR product yield from a representative PCR reaction performed in triplicate. Lines are the fit of models 1 (A), 2 (B) and 3 (C) to the experimental data. Inserts are the residuals for each fit. The determination coefficient (R2), corrected Akike's Information Criterion (AIC) and the best fit value for Ei ± asymptotic standard error are shown in the graphs. Ei for model 3 was calculated from Eq. (3). Model 1 was fitted by linear regression, while models 2 and 3 were fitted by non-linear regression.
Figure 2Effect of CT on the initial template amount estimation. (A) Product yield vs. cycle number for the amplification of three serial dilutions (0.1, 1 and 10) of cDNA from mouse midbrain with β-actin specific primers performed in triplicate. Horizontal lines show the values for the product yield at which CT was calculated. (B) Ratios between each T0 determination and T0 estimated for dilution 1 at the smallest CT value. T0 was calculated assuming constant amplification efficiency and using different amounts of PCR product for the estimation of CT values. Data points are the mean for triplicates. (C) Relative error for the quantification of data presented in A. Bars are the relative error of quantification as percentage (mean ± SEM for triplicates). (D) Real-time PCR amplification of the same mouse midbrain cDNA sample with β2 microglobulin specific primers using 0.1 and 0.25 units of Taq DNA polymerase. Horizontal lines show the values for the product yield at which CT was calculated. (E) Relative error for the quantification of data presented in D. Bars are the relative error of quantification as percentage (mean ± SEM for triplicates).
Estimation of model parameters.
| Mean ± | Correlation | Mean ± | ||||||
| Dilution | SE | SEM | SE | SEM | ||||
| 10 | 8.52 | 2.27 | 8.63 ± | 0.963 | -0.97 | 12.4 | 0.29 | 12.17 ± |
| 10 | 7 | 2 | 0.98 | 0.963 | -0.977 | 11.2 | 0.34 | 0.52 |
| 10 | 10.4 | 1.95 | 0.963 | -0.969 | 12.9 | 0.36 | ||
| 1 | 0.42 | 0.06 | 0.967 | -0.962 | 0.981 | 0.018 | ||
| 1 | 1.08 | 0.56 | 1 ± 0.32 | 0.964 | -0.948 | 0.804 | 0.024 | 1 ± 0.12 |
| 1 | 1.51 | 0.74 | 0.965 | -0.977 | 1.21 | 0.043 | ||
| 0.1 | 0.09 | 0.04 | 0.073 ± | 0.968 | -0.965 | 0.121 | 0.0032 | 0.12 ± |
| 0.1 | 0.065 | 0.015 | 0.0087 | 0.969 | -0.974 | 0.111 | 0.0026 | 0.0028 |
| 0.1 | 0.063 | 0.023 | 0.968 | -0.921 | 0.117 | 0.0028 | ||
Estimation of T0, b and Tm by fitting Eq. (1) and (2) to experimental data (A), and estimation of T0 by fitting Eq. (1) and (2) to experimental data using b and Tm values previously obtained from the fit of Eq. (2) to experimental amplification efficiencies (B). Shown is the dilution of mouse midbrain cDNA used for each real-time PCR run, the best fit values for T0, the asymptotic estimation of the standard error (SE), and the T0 mean value ± standard error of the mean (SEM). For (A), the correlation between T0 and the other parameters estimated by non-linear regression is also shown.
Figure 3Effect of amplification efficiency over the quantifications performed by different methods. (A) In-silico generated PCR data with initial template amount T0 = 0.001 and different intrinsic amplification efficiencies (Ei) ranging from 0.65 to 0.972 analysed by different methods (see below). Data points represent the base 2 logarithm of the ratio between T0 estimations from each simulated reaction and efficiency 0.8 ones vs. the amplification efficiency bias as mean ± SEM of triplicates. (B) Analysis of experimental results by different methods (see below). Bars represent the error of quantifications as mean ± SEM for triplicates. Bars marked with (*) are under-estimations, conversely, the rest of the bars are over-estimations. Method 6 under-estimated T0 by 737%, note that it is out of scale in the graph. Data was analysed with the CT method assuming constant amplification efficiency equal to 1 {1}; with the CT method assuming constant amplification efficiency equal to 0.8 for in-silico data, or 0.855 for experimental data {2}; assuming constant amplification efficiency that was estimated from two threshold values {3} [15]; using the assumption-free analysis proposed by Ramakers et.al. {4} [13]; using the standardized determination of PCR efficiency from single reaction proposed by Tichopad et.al. {5} [16]; using the sigmoid model proposed by Liu et. al. {6} [17]; and with our model based real-time PCR analysis method (MoBPA) {7}.
Analysis of real-time PCR results with similar amplification efficiency among samples. Data represent the quantification of dilutions 0.1 and 10 as the mean ± SEM for 12 experiments performed in triplicate.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| 0.1 | 0.084 ± 0.003 | 0.11 ± 0.0033 | 0.57 ± 0.30 | 0.37 ± 0.19 | 0.75 ± 0.45 | 0.71 ± 0.63 | 0.12 ± 0.022 |
| 1 | 1 ± 0.019 | 1 ± 0.017 | 1 ± 0.11 | 1 ± 0.20 | 1 ± 0.12 | 1 ± 0.10 | 1 ± 0.018 |
| 10 | 14 ± 0.680 | 10 ± 0.35 | 242 ± 206 | 83 ± 52 | 15 ± 5.5 | 48 ± 1.0 | 10 ± 1.1 |
(1)CT method assuming constant amplification efficiency equal to 1 [12].
(2) CT method with amplification efficiency estimated from a dilution series [14].
(3) Amplification efficiency estimated at two product yield thresholds [15].
(4) Amplification efficiency estimated with LinRegPCR software [13].
(5) Amplification efficiency estimated with the Tichopad et.al. approach [16].
(6) Amplification efficiency estimated from the model proposed by Liu et.al. [17].
(7) Our model based real-time PCR analysis method (MoBPA).